Saturday 17 October 2026
Export PDLI’s income statement to Excel — free account
PDL BioPharma, Inc.
Follow PDLI
PDL BioPharma, Inc. (PDLI) P/E ratio
PDL BioPharma, Inc. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (January 2021) to 28.8× (June 2017) — the current reading is the lowest in ten years.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2019 | 0.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 4.0× | (30.29%) |
| FY2016 | 5.7× | 227.90% |
| FY2015 | 1.7× | — |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Jun 2020 | 0.0× | — |
| Mar 2020 | 0.0× | — |
| Dec 2019 | 0.0× | — |
| Sep 2019 | 0.0× | — |
| 18 more quarters | Free account |
Against its own ten years
Low 0.0×
High 28.8×
Ten-year median
2.2×
Current reading's percentile
38
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| PDLI PDL BioPharma, Inc. | n/m |
| Other industry median | 10.3× |
| Other sector median | 10.3× |
| Market median | 18.1× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)